Cook Meredith 4

What Happened
Meredith Cook, Senior Vice President, General Counsel & Secretary of Ani Pharmaceuticals (ANIP), was granted 13,895 restricted shares on 2026-02-26 valued at $77.15 each (total value ≈ $1,071,999). Two days later (2026-02-28) 1,555 shares were surrendered/withheld at $73.90 per share (proceeds ≈ $114,915) to cover tax liabilities.

Key Details

• Transaction types: A (award/acquisition) on 2026-02-26 and F (share withholding for tax liability) on 2026-02-28.
• Award: 13,895 shares @ $77.15 each — aggregate value ~$1,071,999.
• Withheld: 1,555 shares @ $73.90 each — aggregate ~$114,915 (reported as a disposition).
• Vesting: The new restricted stock award vests in four equal annual installments beginning 02/26/2026 (footnote F1).
• Tax withholding note (F2): The filing states shares were withheld for tax purposes and cites exemption under Rule 16(b)-3 in connection with the vesting of 3,040 previously reported restricted shares.
• Shares owned after the transactions: not specified in this filing.
• Filing timeliness: Form 4 was filed 2026-03-02, four days after the primary grant date (appears to be a late filing relative to the typical 2-business-day requirement).

Context
This was primarily a restricted stock award (an acquisition), not an open-market purchase or sale for investment. The subsequent share disposition is a routine tax-withholding action common when restricted shares vest or are granted — it does not necessarily indicate a change in the insider’s view of the company.